Biodexa Pharmaceuticals Plc (BDRX)

Biodexa Pharmaceuticals Income Statement

Financials in millions GBP. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0.38	0.38	0.7	0.58	0.34	0.67
Revenue Growth (YoY)	-34.08%	-45.49%	20.93%	68.51%	-49.11%	-65.22%
Gross Profit	0.38	0.38	0.7	0.58	0.34	0.67
Selling, General & Admin	4.34	4.34	4.54	2.95	4.96	4.16
Research & Development	4.07	4.07	5.11	4.65	6.07	7.84
Other Operating Expenses	-0.01	-0.01	-0.02	-0.02	12.36	-0.02
Operating Expenses	8.4	8.4	9.63	7.58	23.38	11.99
Operating Income	-8.01	-8.01	-8.93	-7	-23.04	-11.32
Interest Expense / Income	0.04	0.04	0.05	0.04	0.43	0.1
Other Expense / Income	-0.57	-0.57	-0.5	-0.94	-0	0.46
Pretax Income	-7.49	-7.49	-8.49	-6.11	-23.47	-11.87
Income Tax	-0.41	-0.41	-0.83	-0.65	-1.28	-1.79
Net Income	-7.08	-7.08	-7.66	-5.46	-22.19	-10.09
Shares Outstanding (Basic)	278	278	5	3	1	1
Shares Change	8714.17%	5544.47%	56.16%	131.18%	122.96%	0.16%
EPS (Basic)	-8.00	-8.00	-620.00	-544.00	-41.44	-4400.00
EPS (Diluted)	-8.00	-8.00	-620.00	-544.00	-41.44	-4400.00
Free Cash Flow	-7.69	-7.69	-7.77	-7.44	-11.32	-8.72
Free Cash Flow Per Share	-11.07	-11.07	-630.95	-944.04	-3319.49	-5700.17
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-2103.41%	-2103.41%	-1277.83%	-1210.73%	-6717.20%	-1679.23%
Profit Margin	-1858.01%	-1858.01%	-1095.28%	-944.64%	-6469.10%	-1496.29%
Free Cash Flow Margin	-2019.16%	-2019.16%	-1111.30%	-1287.72%	-3300.58%	-1293.62%
EBITDA	-7.16	-7.16	-8.1	-5.66	-21.83	-10.49
EBITDA Margin	-1880.31%	-1880.31%	-1158.08%	-979.07%	-6365.01%	-1556.53%
Depreciation & Amortization	0.28	0.28	0.34	0.4	1.21	1.28
EBIT	-7.44	-7.44	-8.44	-6.06	-23.04	-11.77
EBIT Margin	-1953.81%	-1953.81%	-1206.72%	-1048.79%	-6716.91%	-1746.74%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).